Ipca Laboratories Limited (NSE:IPCALAB)
India · Delayed Price · Currency is INR 1,586.00
+16.00 (1.02%)
At close: Mar 27, 2026
Ipca Laboratories Market Cap
Ipca Laboratories has a market cap or net worth of 402.37 billion as of March 27, 2026. Its market cap has increased by 16.43% in one year.
Market Cap
402.37B
Enterprise Value
417.00B
Revenue
95.06B
Ranking
n/a
PE Ratio
43.79
Stock Price
1,586.00
Market Cap Chart
Since June 12, 2002, Ipca Laboratories's market cap has increased from 3.22B to 402.37B, an increase of 12,400.97%. That is a compound annual growth rate of 22.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 402.37B | 11.78% |
| Dec 31, 2025 | 359.98B | -16.30% |
| Dec 31, 2024 | 430.08B | 52.29% |
| Dec 29, 2023 | 282.41B | 32.03% |
| Dec 30, 2022 | 213.90B | -22.18% |
| Dec 31, 2021 | 274.86B | -1.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mankind Pharma | 835.56B |
| Aurobindo Pharma | 759.57B |
| Alkem Laboratories | 649.90B |
| Glenmark Pharmaceuticals | 611.95B |
| Laurus Labs | 552.54B |
| Ajanta Pharma | 359.66B |
| Emcure Pharmaceuticals | 302.09B |
| Gland Pharma | 281.82B |